Role of microparticles in atherothrombosis

A S Leroyer1, A Tedgui, C M Boulanger

  • 1Institut National de la Santé et de la Recherche Médicale (Unit 689), Cardiovascular Research Institute Inserm, Paris, France.

Insights

Microparticles (MPs) are released from activated cells and contribute to atherosclerosis by promoting blood clots and inflammation. Understanding MP clearance could lead to new atherothrombosis treatments.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Cell activation or apoptosis releases microparticles (MPs), which are submicron membrane vesicles.
  • MPs carry cell-specific phospholipids and proteins, including those conferring procoagulant potential.
  • MPs accumulate in atherosclerotic plaques, increasing thrombogenicity and reflecting vascular dysfunction.

Purpose of the Study:

  • To review the role of microparticles in atherothrombosis.
  • To highlight MPs as markers of cellular injury and vascular dysfunction.
  • To explore potential therapeutic strategies targeting MP biology.

Main Methods:

  • Literature review on microparticle formation, composition, and function.
  • Analysis of the role of MPs in atherothrombosis pathogenesis.
  • Discussion of MP clearance mechanisms and therapeutic implications.

Main Results:

  • MPs promote prothrombotic and pro-inflammatory responses.
  • Elevated plasma MP levels, especially endothelial MPs, indicate cellular injury and vascular dysfunction.
  • MPs contribute to a cycle of vascular dysfunction and atherothrombosis.

Conclusions:

  • Microparticles play a critical role in the pathogenesis of atherothrombosis.
  • MPs serve as important biomarkers for vascular health.
  • Further research into MP composition, effects, and clearance may yield novel therapeutic interventions for atherothrombosis.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Micelles01:30

Micelles

Micelle formation is an intricate process that hinges on the properties of amphiphilic or amphipathic molecules and the conditions of the system in which they are found. Amphiphilic molecules, which have both hydrophilic (water-attracting) and hydrophobic (water-repelling) parts, play a critical role in this process.In aqueous environments, these molecules arrange themselves such that their hydrophilic heads are turned towards the water phase, while their hydrophobic tails are oriented away...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...